Angiotensin II Receptor Blockers Market 2027 By Type, Application and Geography | The Insight Partners

Angiotensin II Receptor Blockers Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Type (Azilsartan, Candesartan, Eprosartan, Irbesartan, Losartan, Olmesartan, Telmisartan, Valsartan) ; Application (Hypertension, Cardiovascular Risks, Kidney Failure In Diabetes, Chronic Kidney Diseases) and Geography

Report Code: TIPRE00008624 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Angiotensin is a chemical in body that narrows the blood vessels. This narrowing can increase blood pressure and force the heart to work harder. Angiotensin II receptor blockers help relax the veins and arteries to lower blood pressure and make it easier for heart to pump blood. Angiotensin II receptor blockers block the action of angiotensin II. As a result, the medication allows your veins and arteries to widen (dilate).

MARKET DYNAMICS

Increasing incidence of target diseases such as hypertension, kidney failure from diabetes, across the globe coupled with rising geriatric population is expected to stimulate market growth. For instance, according to American Heart Association statistics 2018, more than 103 million individuals in U.S. suffer from high blood pressure. However, associated side effects (such as severe dizziness, higher than normal potassium levels in the blood (hyperkalemia), swelling of the skin due to a buildup of fluid (angioedema) and drug recalls are the major hindrance for market growth.

MARKET SCOPE

The "Global Angiotensin II Receptor Blockers Market analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Angiotensin II Receptor Blockers Market with detailed market segmentation by type, application, and geography. The Global Angiotensin II Receptor Blockers Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Angiotensin II Receptor Blockers Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Global Angiotensin II Receptor Blockers Market is segmented on the basis of type, and application. On the basis of type, market can be classified as azilsartan, candesartan, eprosartan, irbesartan, losartan, olmesartan, telmisartan, valsartan. Based on application the market is segmented into hypertension, cardiovascular risks, kidney failure in diabetes, chronic kidney diseases.
.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Angiotensin II Receptor Blockers Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Angiotensin II Receptor Blockers Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Angiotensin II Receptor Blockers Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Angiotensin II Receptor Blockers Market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Angiotensin II Receptor Blockers Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Angiotensin II Receptor Blockers Market are anticipated to lucrative growth opportunities in the future with the rising demand for Angiotensin II Receptor Blockers Market in the global market. Below mentioned is the list of few companies engaged in the Angiotensin II Receptor Blockers Market.

The report also includes the profiles of key Angiotensin II Receptor Blockers Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- AstraZeneca
- Daichii Sankyo
- Novartis
- Abbvie
- Lupin
- Takeda
- Zydus Cadila
- Sun Pharmaceutical
- Abbott Laboratories
- ALEMBIC PHARMS LTD.
- MYLAN

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Angiotensin II Receptor Blockers Market - By Type
1.3.2 Angiotensin II Receptor Blockers Market - By Application
1.3.3 Angiotensin II Receptor Blockers Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ANGIOTENSIN II RECEPTOR BLOCKERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ANGIOTENSIN II RECEPTOR BLOCKERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ANGIOTENSIN II RECEPTOR BLOCKERS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANGIOTENSIN II RECEPTOR BLOCKERS - GLOBAL MARKET OVERVIEW
6.2. ANGIOTENSIN II RECEPTOR BLOCKERS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. ANGIOTENSIN II RECEPTOR BLOCKERS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. AZILSARTAN
7.3.1. Overview
7.3.2. Azilsartan Market Forecast and Analysis
7.4. CANDESARTAN
7.4.1. Overview
7.4.2. Candesartan Market Forecast and Analysis
7.5. EPROSARTAN
7.5.1. Overview
7.5.2. Eprosartan Market Forecast and Analysis
7.6. IRBESARTAN
7.6.1. Overview
7.6.2. Irbesartan Market Forecast and Analysis
7.7. LOSARTAN
7.7.1. Overview
7.7.2. Losartan Market Forecast and Analysis
7.8. OLMESARTAN
7.8.1. Overview
7.8.2. Olmesartan Market Forecast and Analysis
7.9. TELMISARTAN
7.9.1. Overview
7.9.2. Telmisartan Market Forecast and Analysis
7.10. VALSARTAN
7.10.1. Overview
7.10.2. Valsartan Market Forecast and Analysis
8. ANGIOTENSIN II RECEPTOR BLOCKERS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HYPERTENSION
8.3.1. Overview
8.3.2. Hypertension Market Forecast and Analysis
8.4. CARDIOVASCULAR RISKS
8.4.1. Overview
8.4.2. Cardiovascular Risks Market Forecast and Analysis
8.5. KIDNEY FAILURE IN DIABETES
8.5.1. Overview
8.5.2. Kidney Failure In Diabetes Market Forecast and Analysis
8.6. CHRONIC KIDNEY DISEASES
8.6.1. Overview
8.6.2. Chronic Kidney Diseases Market Forecast and Analysis
9. ANGIOTENSIN II RECEPTOR BLOCKERS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Angiotensin II Receptor Blockers Market Overview
9.1.2 North America Angiotensin II Receptor Blockers Market Forecasts and Analysis
9.1.3 North America Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Type
9.1.4 North America Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Application
9.1.5 North America Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Countries
9.1.5.1 United States Angiotensin II Receptor Blockers Market
9.1.5.1.1 United States Angiotensin II Receptor Blockers Market by Type
9.1.5.1.2 United States Angiotensin II Receptor Blockers Market by Application
9.1.5.2 Canada Angiotensin II Receptor Blockers Market
9.1.5.2.1 Canada Angiotensin II Receptor Blockers Market by Type
9.1.5.2.2 Canada Angiotensin II Receptor Blockers Market by Application
9.1.5.3 Mexico Angiotensin II Receptor Blockers Market
9.1.5.3.1 Mexico Angiotensin II Receptor Blockers Market by Type
9.1.5.3.2 Mexico Angiotensin II Receptor Blockers Market by Application
9.2. EUROPE
9.2.1 Europe Angiotensin II Receptor Blockers Market Overview
9.2.2 Europe Angiotensin II Receptor Blockers Market Forecasts and Analysis
9.2.3 Europe Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Type
9.2.4 Europe Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Application
9.2.5 Europe Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Angiotensin II Receptor Blockers Market
9.2.5.1.1 Germany Angiotensin II Receptor Blockers Market by Type
9.2.5.1.2 Germany Angiotensin II Receptor Blockers Market by Application
9.2.5.2 France Angiotensin II Receptor Blockers Market
9.2.5.2.1 France Angiotensin II Receptor Blockers Market by Type
9.2.5.2.2 France Angiotensin II Receptor Blockers Market by Application
9.2.5.3 Italy Angiotensin II Receptor Blockers Market
9.2.5.3.1 Italy Angiotensin II Receptor Blockers Market by Type
9.2.5.3.2 Italy Angiotensin II Receptor Blockers Market by Application
9.2.5.4 Spain Angiotensin II Receptor Blockers Market
9.2.5.4.1 Spain Angiotensin II Receptor Blockers Market by Type
9.2.5.4.2 Spain Angiotensin II Receptor Blockers Market by Application
9.2.5.5 United Kingdom Angiotensin II Receptor Blockers Market
9.2.5.5.1 United Kingdom Angiotensin II Receptor Blockers Market by Type
9.2.5.5.2 United Kingdom Angiotensin II Receptor Blockers Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Angiotensin II Receptor Blockers Market Overview
9.3.2 Asia-Pacific Angiotensin II Receptor Blockers Market Forecasts and Analysis
9.3.3 Asia-Pacific Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Angiotensin II Receptor Blockers Market
9.3.5.1.1 Australia Angiotensin II Receptor Blockers Market by Type
9.3.5.1.2 Australia Angiotensin II Receptor Blockers Market by Application
9.3.5.2 China Angiotensin II Receptor Blockers Market
9.3.5.2.1 China Angiotensin II Receptor Blockers Market by Type
9.3.5.2.2 China Angiotensin II Receptor Blockers Market by Application
9.3.5.3 India Angiotensin II Receptor Blockers Market
9.3.5.3.1 India Angiotensin II Receptor Blockers Market by Type
9.3.5.3.2 India Angiotensin II Receptor Blockers Market by Application
9.3.5.4 Japan Angiotensin II Receptor Blockers Market
9.3.5.4.1 Japan Angiotensin II Receptor Blockers Market by Type
9.3.5.4.2 Japan Angiotensin II Receptor Blockers Market by Application
9.3.5.5 South Korea Angiotensin II Receptor Blockers Market
9.3.5.5.1 South Korea Angiotensin II Receptor Blockers Market by Type
9.3.5.5.2 South Korea Angiotensin II Receptor Blockers Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Angiotensin II Receptor Blockers Market Overview
9.4.2 Middle East and Africa Angiotensin II Receptor Blockers Market Forecasts and Analysis
9.4.3 Middle East and Africa Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Angiotensin II Receptor Blockers Market
9.4.5.1.1 South Africa Angiotensin II Receptor Blockers Market by Type
9.4.5.1.2 South Africa Angiotensin II Receptor Blockers Market by Application
9.4.5.2 Saudi Arabia Angiotensin II Receptor Blockers Market
9.4.5.2.1 Saudi Arabia Angiotensin II Receptor Blockers Market by Type
9.4.5.2.2 Saudi Arabia Angiotensin II Receptor Blockers Market by Application
9.4.5.3 U.A.E Angiotensin II Receptor Blockers Market
9.4.5.3.1 U.A.E Angiotensin II Receptor Blockers Market by Type
9.4.5.3.2 U.A.E Angiotensin II Receptor Blockers Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Angiotensin II Receptor Blockers Market Overview
9.5.2 South and Central America Angiotensin II Receptor Blockers Market Forecasts and Analysis
9.5.3 South and Central America Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Type
9.5.4 South and Central America Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Application
9.5.5 South and Central America Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Angiotensin II Receptor Blockers Market
9.5.5.1.1 Brazil Angiotensin II Receptor Blockers Market by Type
9.5.5.1.2 Brazil Angiotensin II Receptor Blockers Market by Application
9.5.5.2 Argentina Angiotensin II Receptor Blockers Market
9.5.5.2.1 Argentina Angiotensin II Receptor Blockers Market by Type
9.5.5.2.2 Argentina Angiotensin II Receptor Blockers Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ANGIOTENSIN II RECEPTOR BLOCKERS MARKET, KEY COMPANY PROFILES
11.1. ASTRAZENECA
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. DAICHII SANKYO
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. NOVARTIS
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ABBVIE
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. LUPIN
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. TAKEDA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ZYDUS CADILA
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SUN PHARMACEUTICAL
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. ABBOTT LABORATORIES
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ALEMBIC PHARMS LTD
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
11.11. MYLAN
11.11.1. Key Facts
11.11.2. Business Description
11.11.3. Products and Services
11.11.4. Financial Overview
11.11.5. SWOT Analysis
11.11.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. AstraZeneca
2. Daichii Sankyo
3. Novartis
4. Abbvie
5. Lupin
6. Takeda
7. Zydus Cadila
8. Sun Pharmaceutical
9. Abbott Laboratories
10. ALEMBIC PHARMS LTD.
11. MYLAN

TIPRE00008624
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking